
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
February Table of Contents
almost 23 years ago
Upping the Antealmost 23 years ago
Knowing When to Pull the Plug On Your Experimental Drug





